| SECURITIES AND EXCHANGE
COMMISSION Washington, D.C. 20549 |
SCHEDULE 13G |
UNDER THE SECURITIES EXCHANGE ACT OF 1934
|
(Amendment
No. 2
)*
|
Klaviyo, Inc. (Name of Issuer) |
Series A common stock, par value $0.001 per share (Title of Class of Securities) |
49845K101 (CUSIP Number) |
12/31/2024 (Date of Event Which Requires Filing of this Statement) |
| Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |
 Rule
13d-1(b) |
| Rule
13d-1(c) |
 Rule
13d-1(d) |
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Accel Growth Fund V L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 1,055,195.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 1.3 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) PN |
Comment for Type of Reporting Person:
Note to Row 5: 1,055,195 shares issuable upon conversion of Series B Common Stock, all of which are directly owned by AGF5. Accel Growth Fund V Associates L.L.C. ("AGF5A"), the general partner of AGF5, may be deemed to have sole power to vote these shares. Ping Li ("PL"), a director of the issuer and a managing member of AGF5A, may be deemed to have shared power to vote these shares.
Note to Row 6: See response to row 5.
Note to Row 7: 1,055,195 shares issuable upon conversion of Series B Common Stock, all of which are directly owned by AGF5. AGF5A, the general partner of AGF5, may be deemed to have sole power to dispose of these shares. PL, a director of the issuer and a managing member of AGF5A, may be deemed to have shared power to dispose of these shares.
Note to Row 8: See response to row 7.
Note to Row 11: Based on 79,859,158 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the Securities and Exchange Commission on November 6, 2024 (the "Form 10-Q"), plus (ii) 1,055,195 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by AGF5.
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Accel Growth Fund V Strategic Partners L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 44,808.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 0.1 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) PN |
Comment for Type of Reporting Person:
Note to Row 5: 44,808 shares issuable upon conversion of Series B Common Stock, all of which are directly owned by AGF5SP. AGF5A, the general partner of AGF5SP, may be deemed to have sole power to vote these shares. PL, a director of the issuer and a managing member of AGF5A, may be deemed to have shared power to vote these shares.
Note to Row 6: See response to row 5.
Note to Row 7: 44,808 shares issuable upon conversion of Series B Common Stock, all of which are directly owned by AGF5SP. AGF5A, the general partner of AGF5SP, may be deemed to have sole power to dispose of these shares. PL, a director of the issuer and a managing member of AGF5A, may be deemed to have shared power to dispose of these shares.
Note to Row 8: See response to row 7.
Note to Row 11: Based on 78,848,771 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in the Form 10-Q, plus (ii) 44,808 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by AGF5SP.
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Accel Growth Fund V Associates L.L.C. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 1,100,003.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 1.4 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) OO |
Comment for Type of Reporting Person:
Note to Row 5: 1,100,003 shares issuable upon conversion of Series B Common Stock, of which 1,055,195 are directly owned by AGF5, and 44,808 are directly owned by AGF5SP. AGF5A, the general partner of AGF5 and AGF5SP, may be deemed to have sole power to vote these shares. PL, a director of the issuer and a managing member of AGF5A, may be deemed to have shared power to vote these shares.
Note to Row 6: See response to row 5.
Note to Row 7: 1,100,003 shares issuable upon conversion of Series B Common Stock, of which 1,055,195 are directly owned by AGF5, and 44,808 are directly owned by AGF5SP. AGF5A, the general partner of AGF5 and AGF5SP, may be deemed to have sole power to dispose of these shares. PL, a director of the issuer and a managing member of AGF5A, may be deemed to have shared power to dispose of these shares.
Note to Row 8: See response to row 7.
Note to Row 11: Based on 79,903,966 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in the Form 10-Q, plus (ii) 1,055,195 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by AGF5, plus (iii) 44,808 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by AGF5SP.
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Accel Growth Fund V Investors (2019) L.L.C. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 54,855.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 0.1 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) OO |
Comment for Type of Reporting Person:
Note to Row 5: 54,855 shares issuable upon conversion of Series B Common Stock, all of which are directly owed by AGFI19. PL, a director of the issuer and a managing member of AGF19, may be deemed to have shared power to vote these shares.
Note to Row 6: See response to row 5.
Note to Row 7: 54,855 shares issuable upon conversion of Series B Common Stock, all of which are directly owed by AGFI19. PL, a director of the issuer and a managing member of AGF19, may be deemed to have shared power to dispose of these shares.
Note to Row 8: See response to row 7.
Note to Row 11: Based on 78,858,818 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in the Form 10-Q, plus (ii) 54,855 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by AGFI19.
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Accel Leaders Fund II L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 3,163,506.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 3.9 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) PN |
Comment for Type of Reporting Person:
Note to Row 5: 3,163,506 shares issuable upon conversion of Series B Common Stock, all of which are directly owned by ALF2. Accel Leaders Fund II Associates L.L.C. ("ALF2A"), the general partner of ALF2, may be deemed to have sole power to vote these shares. PL, a director of the issuer and a managing member of ALF2A, may be deemed to have shared power to vote these shares.
Note to Row 6: See response to row 5.
Note to Row 7: 3,163,506 shares issuable upon conversion of Series B Common Stock, all of which are directly owned by ALF2. ALF2A, the general partner of ALF2, may be deemed to have shared power to dispose of these shares. PL, a director of the issuer and a managing member of ALF2A, may be deemed to have shared power to vote these shares.
Note to Row 8: See response to row 7.
Note to Row 11: Based on 81,967,469 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in the Form 10-Q, plus (ii) 3,163,506 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by ALF2.
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Accel Leaders Fund II Strategic Partners L.P. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 134,772.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 0.2 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) PN |
Comment for Type of Reporting Person:
Note to Row 5: 134,772 shares issuable upon conversion of Series B Common Stock, all of which are directly owned by ALF2SP. ALF2A, the general partner of ALF2SP, may be deemed to have sole power to vote these shares. PL, a director of the issuer and a managing member of ALF2A, may be deemed to have shared power to vote these shares.
Note to Row 6: See response to row 5.
Note to Row 7: 134,772 shares issuable upon conversion of Series B Common Stock, all of which are directly owned by ALF2SP. ALF2A, the general partner of ALF2SP, may be deemed to have shared power to dispose of these shares. PL, a director of the issuer and a managing member of ALF2A, may be deemed to have shared power to dispose of these shares.
Note to Row 8: See response to row 7.
Note to Row 11: Based on 78,938,735 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in the Form 10-Q, plus (ii) 134,772 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by ALF2SP.
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Accel Leaders Fund II Associates L.L.C. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 3,298,278.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 4.0 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) OO |
Comment for Type of Reporting Person:
Note to Row 5: 3,298,278 shares issuable upon conversion of Series B Common Stock, of which 3,163,506 are directly owned by ALF2 and 134,772 are directly owned by ALF2SP. ALF2A, the general partner of ALF2 and ALF2SP, may be deemed to have sole power to vote these shares. PL, a director of the issuer and a managing member of ALF2A, may be deemed to have shared power to vote these shares.
Note to Row 6: See response to row 5.
Note to Row 7: 3,298,278 shares issuable upon conversion of Series B Common Stock, of which 3,163,506 are directly owned by ALF2 and 134,772 are directly owned by ALF2SP. ALF2A, the general partner of ALF2 and ALF2SP, may be deemed to have sole power to dispose of these shares. PL, a director of the issuer and a managing member of ALF2A, may be deemed to have shared power to dispose of these shares.
Note to Row 8: See response to row 7.
Note to Row 11: Based on 82,102,241 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in the Form 10-Q, plus (ii) 3,163,506 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by ALF2, plus (iii) 134,772 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by ALF2SP.
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Accel Leaders Fund II Investors (2019) L.L.C. | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization DELAWARE | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 166,299.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 0.2 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) OO |
Comment for Type of Reporting Person:
Note to Row 5: 166,299 shares issuable upon conversion of Series B Common Stock, all of which are directly owed by ALFI19. PL, a director of the issuer and a managing member of ALFI19, may be deemed to have shared power to vote these shares.
Note to Row 6: See response to row 5.
Note to Row 7: 166,299 shares issuable upon conversion of Series B Common Stock, all of which are directly owed by ALFI19. PL, a director of the issuer and a managing member of ALFI19, may be deemed to have shared power to dispose of these shares.
Note to Row 8: See response to row 7.
Note to Row 11: Based on 78,970,262 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in the Form 10-Q, plus (ii) 166,299 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by ALFI19.
SCHEDULE 13G |
| CUSIP No. | 49845K101 |
| 1 | Names of Reporting Persons Li Ping | ||||||||
| 2 | Check the appropriate box if a member of a Group (see
instructions)
(a)
(b) | ||||||||
| 3 | Sec Use Only | ||||||||
| 4 | Citizenship or Place of Organization UNITED STATES | ||||||||
| Number of Shares Beneficially Owned by Each Reporting Person With: |
| ||||||||
| 9 | Aggregate Amount Beneficially Owned by Each Reporting
Person 4,619,435.00 | ||||||||
| 10 | Check box if the aggregate amount in row (9) excludes
certain shares (See Instructions) | ||||||||
| 11 | Percent of class represented by amount in row (9) 5.6 % | ||||||||
| 12 | Type of Reporting Person (See Instructions) IN |
Comment for Type of Reporting Person:
Note to Row 6: 4,619,435 shares issuable upon conversion of Series B Common Stock, of which 1,055,195 are directly owned by AGF5, 44,808 are directly owned by AGF5SP, 54,855 are directly owned by AGFI19, 3,163,506 are directly owned by ALF2, 134,772 are directly owned by ALF2SP, and 166,299 are directly owned by ALFI19. AGF5A, the general partner of AGF5 and AGF5SP, may be deemed to have sole power to vote these shares. ALF2A, the general partner of ALF2 and ALF2SP, may be deemed to have sole power to vote these shares. PL, a director of the issuer and a managing member of AGF5A, AGFI19, ALF2A and ALFI19, may be deemed to have shared power to vote these shares.
Note to Row 8: 4,619,435 shares issuable upon conversion of Series B Common Stock, of which 1,055,195 are directly owned by AGF5, 44,808 are directly owned by AGF5SP, 54,855 are directly owned by AGFI19, 3,163,506 are directly owned by ALF2, 134,772 are directly owned by ALF2SP, and 166,299 are directly owned by ALFI19. AGF5A, the general partner of AGF5 and AGF5SP, may be deemed to have sole power to dispose of these shares. ALF2A, the general partner of ALF2 and ALF2SP, may be deemed to have sole power to dispose of these shares. PL, a director of the issuer and a managing member of AGF5A, AGFI19, ALF2A and ALFI19, may be deemed to have shared power to dispose of these shares.
Note to Row 11: Based on 83,423,398 shares of Series A Common stock, calculated as follows, (i) 78,803,963 shares of Series A Common Stock outstanding as of October 31, 2024, as reported by the issuer in the Form 10-Q, plus (ii) 1,055,195 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by AGF5, plus (iii) 44,808 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by AGF5SP, plus (iv) 54,855 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by AGFI19, plus (v) 3,163,506 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by ALF2, plus (vi) 134,772 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by ALF2SP, plus (vii) 166,299 shares of Series A Common Stock issuable upon conversion of shares of Series B Common Stock held by ALFI19.
SCHEDULE 13G |
| Item 1. | ||
| (a) | Name of issuer: Klaviyo, Inc. | |
| (b) | Address of issuer's principal executive
offices: 125 Summer Street, 6th Floor Boston, MA, 02110 | |
| Item 2. | ||
| (a) | Name of person filing: This joint Schedule 13G is being filed by Accel Growth Fund V L.P. ("AGF5"), Accel Growth Fund V Strategic Partners L.P. ("AGF5SP"), Accel Growth Fund V Associates L.L.C. ("AGF5A"), Accel Growth Fund V Investors (2019) L.L.C. ("AGFI19"), Accel Leaders Fund II L.P. ("ALF2"), Accel Leaders Fund II Strategic Partners L.P. ("ALF2SP"), Accel Leaders Fund II Associates L.L.C. ("ALF2A"), Accel Leaders Fund II Investors (2019) L.L.C. ("ALFI19") and Ping Li ("PL"). The foregoing entities and individuals are collectively referred to as the "Reporting Persons."
AGF5A, the general partner of AGF5 and AGF5SP, may be deemed to have sole power to vote and sole power to dispose of the shares of the issuer directly owned by AGF5 and AGF5SP. ALF2A, the general partner of ALF2 and ALF2SP, may be deemed to have sole power to vote and sole power to dispose of the shares of the issuer directly owned by ALF2 and ALF2SP. PL, a director of the issuer and managing member of AGF5A, AGFI19, ALF2A and ALFI19, may be deemed to have shared power to vote and shared power to dispose of these shares. | |
| (b) | Address or principal business office or, if
none, residence: Accel
500 University Avenue
Palo Alto, CA 94301 | |
| (c) | Citizenship: AGF5, AGF5SP, ALF2, and ALF2SP are Delaware limited partnerships. AGF5A, AGFI19, ALF2A, and ALFI19 are Delaware limited liability companies. PL is a United States Citizen. | |
| (d) | Title of class of securities: Series A common stock, par value $0.001 per share | |
| (e) | CUSIP No.: 49845K101 | |
| Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: | |
| (a) | Broker
or dealer registered under section 15 of the Act (15 U.S.C. 78o); | |
| (b) | Bank
as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); | |
| (c) | Insurance
company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); | |
| (d) | Investment
company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); | |
| (e) | An
investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E); | |
| (f) | An
employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F); | |
| (g) | A
parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G); | |
| (h) | A
savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C.
1813); | |
| (i) | A
church plan that is excluded from the definition of an investment company under section 3(c)(14)
of the Investment Company Act of 1940 (15 U.S.C. 80a-3); | |
| (j) | A
non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S.
institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution: | |
| (k) | Group,
in accordance with Rule 240.13d-1(b)(1)(ii)(K). | |
| Item 4. | Ownership | |
| (a) | Amount beneficially owned: See Row 9 of cover page for each Reporting Person. | |
| (b) | Percent of class: See Row 11 of cover page for each Reporting Person. % | |
| (c) | Number of shares as to which the person has: | |
| (i) Sole power to vote or to direct the vote: See Row 5 of cover page for each Reporting Person. | ||
| (ii) Shared power to vote or to direct the
vote: See Row 6 of cover page for each Reporting Person. | ||
| (iii) Sole power to dispose or to direct the
disposition of: See Row 7 of cover page for each Reporting Person. | ||
| (iv) Shared power to dispose or to direct the
disposition of: See Row 8 of cover page for each Reporting Person. | ||
| Item 5. | Ownership of 5 Percent or Less of a Class. | |
| Item 6. | Ownership of more than 5 Percent on Behalf of Another Person. | |
If any other person is known to have the right to receive or the power to direct
the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to
that effect should be included in response to this item and, if such interest relates to more
than 5 percent of the class, such person should be identified. A listing of the shareholders of
an investment company registered under the Investment Company Act of 1940 or the beneficiaries
of employee benefit plan, pension fund or endowment fund is not required.
Under certain circumstances set forth in the limited partnership agreements of AGF5, AG5SP, ALF2, and ALF2SP, and the limited liability company agreements of AGF5A, AGFI19, ALF2A, and ALFI19, the general partner and limited partners or members, as the case may be, of each of such entities may be deemed to have the right to receive dividends from, or the proceeds from, the sale of shares of the issuer owned by each such entity of which they are a partner or member, as the case may be. | ||
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. | |
Not Applicable
| ||
| Item 8. | Identification and Classification of Members of the Group. | |
Not Applicable
| ||
| Item 9. | Notice of Dissolution of Group. | |
Not Applicable
| ||
| Item 10. | Certifications: |
Not Applicable
|
| SIGNATURE | |
After reasonable inquiry and to the
best of my knowledge and belief, I certify that the information set forth in this statement is
true, complete and correct. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comments accompanying signature:
Signed pursuant to a Power of Attorney already on file with the appropriate agencies.
Exhibit
Information |
Exhibit A: Agreement of Joint Filing |